Active case treatment lebih cost effective untuk pengobatan TB paru tahap awal
Date
2012
Journal Title
Journal ISSN
Volume Title
Publisher
Pusat Kebijakan dan Manajemen Kesehatan, Universitas Gadjah Mada, Yogyakarta, ID
Abstract
Background: Estimated one third of world population have
been infected with Mycobacterium tuberculosis. Infected person
will lose 3-4 months work time and will decrease 20%-
30% of income per year. Finding and treating TB patients are
the best endeavor to stop TB spreading with a correct intervention.
Jember Regency is executing Passive Case Treatment
(PCT), which lung TB patients should come to puskesmas
to take the Tuberculosis Drug (ATD) in a certain day and
hour. The method was not effective, proven by the increase of
default rate for 3 years: 5.08% in 2007, 5.14% in 2008 and
6.18% in 2009, followed by the decrease of conversion rate
for 3 years: 95.26% in 2007, 93.09% in 2008 and 92.08% in
2009. It is raising alertness for increased re-treatment which
will lead to MDR, where MDR is clearly affecting TB patients’
quality of life. Afterward, an idea to create an ATD delivery to
patients’ homes was executed, it is called Active Case Treatment
(ACT).
Method: This study was a Quasy Experimental Research
with a prospective design. Conducted in 16 Puskesmas with
default rate more than 5% and conversion rate less than 80%
in 2009. Begin in September until November 2010, using total
sampling technique. The sample was all lung TB patients who
came for treatment in September 2010, with criteria were:
new case, 15-50 years of age, did not suffer HIV and Diabetes
Mellitus, was not malnourished, and was not allergic to
ATD. Data collection was done through interview, filling questionnaires
and exploring documents. Then followed the calculation
of the total cost (direct and indirect cost) and Quality of
Life (QoL) of both PCT and ACT. Later, total cost was compared
to QoL, the lesser amount was considered more cost
effective.
Result: Research result showed that to increase 1 scale of
Quality of Life (QoL) of PCT needed an amount of IDR. 35,295.00,
while to increase 1 QoL scale ACT was IDR 14,377.00. ACT
was smaller than PCT.
Conclution: Conclusion derived from the result was that ACT
is more cost effective than PCT. Recommendation to be presented
is to endorse lung TB treatment with ACT in Jember
Regency particularly in Puskesmas with the same characteristics
with this research.
Description
item.page.type
Journal Article (peer-reviewed)
item.page.format
Text
Keywords
INDONESIA, TUBERCULOSIS, ACCESS TO HEALTH CARE, EPIDEMIOLOGY, MEDICAL CARE, EARLY DETECTION OF DISEASE, ANTITUBERCULAR AGENTS, LUNG DISEASES
Citation
Ketut Ardani, N., Nurul Rochmah, T., & Umbul Wahyuni, C. (2012). Active case treatment lebih cost effective untuk pengobatan TB paru tahap awal. Jurnal Kebijakan Kesehatan Indonesia, 1(2): 103-111.